|Bid||9.63 x 1000|
|Ask||9.70 x 800|
|Day's Range||9.56 - 9.77|
|52 Week Range||4.75 - 10.99|
|Beta (5Y Monthly)||0.61|
|PE Ratio (TTM)||28.58|
|Earnings Date||Nov 12, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||14.00|
Electromed, Inc. (NYSEMKT:ELMD) shareholders might be concerned after seeing the share price drop 11% in the last...
Electromed (NYSEMKT:ELMD) shares have continued recent momentum with a 32% gain in the last month alone. That brought...
After reading Electromed, Inc.'s (AMEX:ELMD) most recent earnings announcement (30 September 2019), I found it useful...
A week ago, Electromed, Inc. (NYSEMKT:ELMD) came out with a strong set of first-quarter numbers that could potentially...
It's really great to see that even after a strong run, Electromed (NYSEMKT:ELMD) shares have been powering on, with a...
Net income of $1.0 million primarily driven by 14.1% revenue growth from prior year period and 16.2% operating margin
Electromed, Inc. , a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2020 first quarter ended September 30, 2019 on Tuesday, November 12, 2019 after the close of the stock market.
This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios...
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
Today we are going to look at Electromed, Inc. (NYSEMKT:ELMD) to see whether it might be an attractive investment...
Electromed, Inc. today announced that a new, first-of-its-kind study published in BMC Pulmonary Medicine found that use of the SmartVest® Airway Clearance System as part of a treatment algorithm significantly decreased exacerbations requiring hospitalization and antibiotic use among non-CF bronchiectasis patients.
Electromed, Inc. (NYSEMKT:ELMD) shareholders have seen the share price descend 19% over the month. But that scarcely...
Electromed, Inc. , a leader in innovative airway clearance technologies, today announced financial results for the three months ended March 31, 2019 .
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Bud Reeves has joined the Company as Vice President of Sales and will oversee all domestic sales initiatives to accelerate revenue growth. Bud has over 20 years of sales and marketing leadership experience in the healthcare industry and brings a history of strong execution of growth strategies and proven results, specifically in emerging respiratory markets. “Bud has a wealth of experience in the respiratory industry and in developing high performing sales teams,” said Kathleen Skarvan, President and Chief Executive Officer of Electromed.